ASX/RMD (ASX/RMD)

Australian Securities Exchange: ASX/RMD · AUD

A$35.1

-0.37 (-1.0%)· Recorded snapshot

Market cap	50.2B
Revenue (ttm)	8.2B
Net income (ttm)	2.2B
EPS (ttm)	A$1.48
P/E (trailing)	23.7x
P/E (forward)	20.7x
Dividend	A$0.34 (0.98%)
Volume	2,185,169
Beta	0.75

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 8.2B
Net income (ttm): 2.2B
EPS (ttm): A$1.48
P/E (trailing): 23.7x
P/E (forward): 20.7x
Market cap: 50.2B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E20.7

P25 n/aP50 n/aP75 n/a

Trailing P/E23.7

P25 n/aP50 n/aP75 n/a

ROE24.3

P25 n/aP50 n/aP75 n/a

ROIC26.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

S&P 500+0.8%

Nasdaq Composite-1.0%

Dow Jones Industrial Average+1.9%

Russell 2000+0.3%

All ASX/RMD indicators

Market & fundamental data

Available fields

263

Groups with data

Currency

USD

Showing 263 of 263 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	United States
Country code	AU
Earnings date	2026-10-29
Employees	11,370
Employees change	770
Employees growth	7.26%
Enterprise value	AUD 49.2B
Exchange	Australian Securities Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	1989
In index	ASX200
Industry	Medical Instruments & Supplies
Is primary listing	No
ISIN number	AU000000RMD6
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split date	2010-08-12
Last stock split type	Forward
Market cap	AUD 50.2B
Next earnings date	2026-10-29
Price	AUD 35.13
Price currency	AUD
Sector	Healthcare
SIC code	3845
Stock price date	2026-10-28
Symbol	asx/RMD
Website	https://www.resmed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	38.58x
Average P/E ratio (3Y)	26.06x
Average P/E ratio (5Y)	34.94x
Earnings yield	4.22%
EV/Earnings	22.36x
EV/EBIT	17.97x
EV/EBITDA	16.12x
EV/FCF	20.65x
EV/Sales	6.13x
FCF / EV yield	4.84%
FCF yield	4.75%
Forward P/E	20.73x
Graham number	15.21239
Graham upside	-56.7%
Industry P/E	22.96x
Lynch fair value	AUD 38.56
Lynch upside	9.77%
P/(FCF - SBC) ratio	22.45x
P/(OCF - SBC) ratio	20.39x
P/B ratio	5.27x
P/E ratio	23.7x
P/FCF ratio	21.03x
P/OCF ratio	19.21x
P/S ratio	6.14x
Price / tangible book value	10.76x
Price/EBITDA ratio	16.55x
Sector forward P/E	33.76x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	33.96%
EBITDA margin	37.07%
Effective tax rate	20.64%
FCF margin	29.67%
Gross margin	61.62%
Operating margin	33.96%
Pretax margin	33.95%
Profit margin	26.94%
Profit per employee	AUD 193,661
Profitable quarters	21
Profitable years	34
Revenue per employee	AUD 718,738
ROA	14%
ROA (5Y)	13.12%
ROCE	25.36%
ROE	24.27%
ROE (5Y)	24.35%
ROIC	26.23%
ROIC (5Y)	22.79%
SBC / revenue	1.85%
Tax / revenue	7.01%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	9.67%
EPS growth (Q)	2.39%
EPS growth (QoQ)	-3.55%
EPS growth 10Y	15.4%
EPS growth 3Y	19.64%
EPS growth 5Y	26.34%
EPS growth years	5
FCF growth	-0.73%
FCF growth (Q)	-20.6%
FCF growth (QoQ)	-22.47%
FCF growth 3Y	42.2%
FCF growth 5Y	21.07%
Gross profit growth	12.84%
Gross profit growth (Q)	4.83%
Gross profit growth 3Y	13.44%
Gross profit growth 5Y	13.02%
Net income growth	8.75%
Net income growth (Q)	0.98%
Net income growth (QoQ)	-3.84%
Net income growth 3Y	19.28%
Net income growth 5Y	26.27%
Net income growth years	5
OCF growth	3.1%
OCF growth (Q)	-15.62%
OCF growth (QoQ)	-17.96%
OCF growth 10Y	12.67%
OCF growth 3Y	37.59%
OCF growth 5Y	19.64%
Operating income growth	13.78%
Operating income growth (Q)	-1.08%
Operating income growth 3Y	18.56%
Operating income growth 5Y	15.91%
Revenue growth	9.85%
Revenue growth (Q)	8.58%
Revenue growth (QoQ)	2.25%
Revenue growth 10Y	11.89%
Revenue growth 3Y	10.21%
Revenue growth 5Y	12.08%
Revenue growth quarters	21
Revenue growth years	33

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	AUD -225.9M
Depreciation and amortization	AUD 249.9M
EBIT	AUD 2.8B
EBITDA	AUD 3B
EPS	AUD 1.48
Financing cash flow	AUD -1.5B
Free cash flow	AUD 2.4B
Free cash flow minus SBC	AUD 2.2B
Gross profit	AUD 5B
Income taxes	AUD 572.6M
Investing cash flow	AUD -788.1M
Net borrowing	AUD -14.2M
Net cash flow	AUD 375.5M
Net income	AUD 2.2B
Operating cash flow minus SBC	AUD 2.5B
Operating income	AUD 2.8B
Revenue	AUD 8.2B
Stock-based compensation	AUD 150.8M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	11.92
Book value per share	AUD 66.00
Debt / EBITDA	0.39
Debt / equity	0.13
Debt / FCF	0.5
Goodwill	AUD 4.1B
Long-term assets	AUD 6.8B
Long-term liabilities	AUD 1.5B
Net cash (debt)	AUD 929.9M
Net cash / market cap	1.85%
Net cash growth	79.88%
Net debt / EBITDA	-0.31
Net debt / equity	-0.1
Net debt / FCF	-0.39
Piotroski F-Score	6
Property, plant and equipment	AUD 1B
Shareholders' equity	AUD 9.5B
Tangible book value	AUD 4.7B
Tangible book value per share	AUD 32.30
Total assets	AUD 13B
Total cash	AUD 2.1B
Total debt	AUD 1.2B
Total liabilities	AUD 3.4B
WACC	8.18%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.66
Current assets	AUD 6.1B
Current liabilities	AUD 2B
Current ratio	3.1
Inventory turnover	2.23
Net working capital	AUD 2.5B
Quick ratio	1.83
Working capital	AUD 4.2B
Working capital turnover	3.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.87%
Dividend growth	13.26%
Dividend growth (10Y)	8.07%
Dividend growth (3Y)	-25.16%
Dividend growth (5Y)	9.1%
Dividend growth years	1
Dividend payment date	2026-09-24
Dividend payment years	15
Dividend payout frequency	Quarterly
Dividend per share	AUD 0.34
Dividend yield	0.98%
Ex-dividend date	2026-08-19
Last dividend	AUD 0.07
Payout ratio	22.95%
Shareholder yield	1.85%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	342.44%
10Y return CAGR	17.52%
10Y total return	402.22%
150-day SMA	AUD 30.53
15Y price change	1,256.37%
15Y return CAGR	20.58%
15Y total return	1,555.64%
1D price change	-1.04%
1M price change	11.24%
1M total return	11.24%
1W price change	0.69%
1W total return	0.69%
1Y price change	-12%
1Y return CAGR	-11.07%
1Y total return	-11.06%
20-day SMA	AUD 33.62
200-day SMA	AUD 31.81
20Y price change	1,101.03%
20Y return CAGR	14.37%
20Y total return	1,366.02%
3M price change	25.46%
3M total return	25.84%
3Y price change	62.94%
3Y return CAGR	18.84%
3Y total return	67.84%
50-day SMA	AUD 32.52
50-day SMA vs 200-day SMA	50over200
52-week high	AUD 40.08
52-week high date	2025-10-31
52-week low	AUD 25.50
52-week low date	2026-06-03
5Y price change	-2.69%
5Y return CAGR	0.71%
5Y total return	3.61%
6M price change	15.26%
6M total return	15.95%
All-time high	AUD 45.25
All-time high date	2025-08-25
All-time low	AUD 0.79
All-time low date	2000-01-07
Average true range (ATR)	AUD 0.58
Average volume	1.4M
Beta (5Y)	0.75
Change from 52-week high	-12.35%
Change from 52-week low	37.77%
Change from all-time high	-22.36%
Change from all-time low	4,353.6%
Change from open	-0.9%
Day's gap	-0.14%
Dollar volume	AUD 76.8M
High price	AUD 35.72
Low price	AUD 35.01
Monthly RSI	52.2
Open price	AUD 35.45
Position in 52-week range	16.9%
Previous close	AUD 35.50
Price vs 150-day SMA	15.06%
Price vs 20-day SMA	4.5%
Price vs 200-day SMA	10.45%
Price vs 50-day SMA	8.04%
Relative volume	1.51
RSI	67.58
Sharpe ratio	-0.29
Sharpe ratio (3Y)	0.52
Sharpe ratio (5Y)	0.03
Sortino ratio	-0.21
Sortino ratio (3Y)	0.94
Sortino ratio (5Y)	0.24
Volume	2.2M
Weekly RSI	60.34
YTD price change	-2.25%
YTD total return	-1.45%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	139.8M
Shares change (QoQ)	-0.51%
Shares change (YoY)	-0.87%
Shares held by insiders	0.49%
Shares held by institutions	80.41%
Short ratio	9.1 days

Deeper analysis on ASX/RMD

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this ASX/RMD report

Is a complete ASX/RMD research report available?

No complete published report is available for asx/RMD (ASX/RMD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap

50.2B

Revenue (ttm)

8.2B

Net income (ttm)

2.2B

EPS (ttm)

A$1.48

P/E (trailing)

23.7x

P/E (forward)

20.7x

Dividend

A$0.34 (0.98%)

Volume

2,185,169

Beta

0.75

Metric

Value

Amount currency

AUD

Country

United States

Country code

Earnings date

2026-10-29

Employees

11,370

Employees change

770

Employees growth

7.26%

Enterprise value

AUD 49.2B

Exchange

Australian Securities Exchange

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-10

Fiscal year end

June

Founded

1989

In index

ASX200

Industry

Medical Instruments & Supplies

Is primary listing

ISIN number

AU000000RMD6

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split date

2010-08-12

Last stock split type

Forward

Market cap

AUD 50.2B

Next earnings date

2026-10-29

Price

AUD 35.13

Price currency

AUD

Sector

Healthcare

SIC code

3845

Stock price date

2026-10-28

Symbol

asx/RMD

Website

https://www.resmed.com

Metric

Value

Average P/E ratio (10Y)

38.58x

Average P/E ratio (3Y)

26.06x

Average P/E ratio (5Y)

34.94x

Earnings yield

4.22%

EV/Earnings

22.36x

EV/EBIT

17.97x

EV/EBITDA

16.12x

EV/FCF

20.65x

EV/Sales

6.13x

FCF / EV yield

4.84%

FCF yield

4.75%

Forward P/E

20.73x

Graham number

15.21239

Graham upside

-56.7%

Industry P/E

22.96x

Lynch fair value

AUD 38.56

Lynch upside

9.77%

P/(FCF - SBC) ratio

22.45x

P/(OCF - SBC) ratio

20.39x

P/B ratio

5.27x

P/E ratio

23.7x

P/FCF ratio

21.03x

P/OCF ratio

19.21x

P/S ratio

6.14x

Price / tangible book value

10.76x

Price/EBITDA ratio

16.55x

Sector forward P/E

33.76x

Metric

Value

EBIT margin

33.96%

EBITDA margin

37.07%

Effective tax rate

20.64%

FCF margin

29.67%

Gross margin

61.62%

Operating margin

33.96%

Pretax margin

33.95%

Profit margin

26.94%

Profit per employee

AUD 193,661

Profitable quarters

Profitable years

Revenue per employee

AUD 718,738

ROA

14%

ROA (5Y)

13.12%

ROCE

25.36%

ROE

24.27%

ROE (5Y)

24.35%

ROIC

26.23%

ROIC (5Y)

22.79%

SBC / revenue

1.85%

Tax / revenue

7.01%

Metric

Value

EPS growth

9.67%

EPS growth (Q)

2.39%

EPS growth (QoQ)

-3.55%

EPS growth 10Y

15.4%

EPS growth 3Y

19.64%

EPS growth 5Y

26.34%

EPS growth years

FCF growth

-0.73%

FCF growth (Q)

-20.6%

FCF growth (QoQ)

-22.47%

FCF growth 3Y

42.2%

FCF growth 5Y

21.07%

Gross profit growth

12.84%

Gross profit growth (Q)

4.83%

Gross profit growth 3Y

13.44%

Gross profit growth 5Y

13.02%

Net income growth

8.75%

Net income growth (Q)

0.98%

Net income growth (QoQ)

-3.84%

Net income growth 3Y

19.28%

Net income growth 5Y

26.27%

Net income growth years

OCF growth

3.1%

OCF growth (Q)

-15.62%

OCF growth (QoQ)

-17.96%

OCF growth 10Y

12.67%

OCF growth 3Y

37.59%

OCF growth 5Y

19.64%

Operating income growth

13.78%

Operating income growth (Q)

-1.08%

Operating income growth 3Y

18.56%

Operating income growth 5Y

15.91%

Revenue growth

9.85%

Revenue growth (Q)

8.58%

Revenue growth (QoQ)

2.25%

Revenue growth 10Y

11.89%

Revenue growth 3Y

10.21%

Revenue growth 5Y

12.08%

Revenue growth quarters

Revenue growth years

Metric

Value

Capital expenditures

AUD -225.9M

Depreciation and amortization

AUD 249.9M

EBIT

AUD 2.8B

EBITDA

AUD 3B

EPS

AUD 1.48

Financing cash flow

AUD -1.5B

Free cash flow

AUD 2.4B

Free cash flow minus SBC

AUD 2.2B

Gross profit

AUD 5B

Income taxes

AUD 572.6M

Investing cash flow

AUD -788.1M

Net borrowing

AUD -14.2M

Net cash flow

AUD 375.5M

Net income

AUD 2.2B

Operating cash flow minus SBC

AUD 2.5B

Operating income

AUD 2.8B

Revenue

AUD 8.2B

Stock-based compensation

AUD 150.8M

Metric

Value

Altman Z-Score

11.92

Book value per share

AUD 66.00

Debt / EBITDA

0.39

Debt / equity

0.13

Debt / FCF

0.5

Goodwill

AUD 4.1B

Long-term assets

AUD 6.8B

Long-term liabilities

AUD 1.5B

Net cash (debt)

AUD 929.9M

Net cash / market cap

1.85%

Net cash growth

79.88%

Net debt / EBITDA

-0.31

Net debt / equity

-0.1

Net debt / FCF

-0.39

Piotroski F-Score

Property, plant and equipment

AUD 1B

Shareholders' equity

AUD 9.5B

Tangible book value

AUD 4.7B

Tangible book value per share

AUD 32.30

Total assets

AUD 13B

Total cash

AUD 2.1B

Total debt

AUD 1.2B

Total liabilities

AUD 3.4B

WACC

8.18%

Metric

Value

Asset turnover

0.66

Current assets

AUD 6.1B

Current liabilities

AUD 2B

Current ratio

3.1

Inventory turnover

2.23

Net working capital

AUD 2.5B

Quick ratio

1.83

Working capital

AUD 4.2B

Working capital turnover

3.02

Metric

Value

Buyback yield / dilution

0.87%

Dividend growth

13.26%

Dividend growth (10Y)

8.07%

Dividend growth (3Y)

-25.16%

Dividend growth (5Y)

9.1%

Dividend growth years

Dividend payment date

2026-09-24

Dividend payment years

Dividend payout frequency

Quarterly

Dividend per share

AUD 0.34

Dividend yield

0.98%

Ex-dividend date

2026-08-19

Last dividend

AUD 0.07

Payout ratio

22.95%

Shareholder yield

1.85%

Metric

Value

10Y price change

342.44%

10Y return CAGR

17.52%

10Y total return

402.22%

150-day SMA

AUD 30.53

15Y price change

1,256.37%

15Y return CAGR

20.58%

15Y total return

1,555.64%

1D price change

-1.04%

1M price change

11.24%

1M total return

11.24%

1W price change

0.69%

1W total return

0.69%

1Y price change

-12%

1Y return CAGR

-11.07%

1Y total return

-11.06%

20-day SMA

AUD 33.62

200-day SMA

AUD 31.81

20Y price change

1,101.03%

20Y return CAGR

14.37%

20Y total return

1,366.02%

3M price change

25.46%

3M total return

25.84%

3Y price change

62.94%

3Y return CAGR

18.84%

3Y total return

67.84%

50-day SMA

AUD 32.52

50-day SMA vs 200-day SMA

50over200

52-week high

AUD 40.08

52-week high date

2025-10-31

52-week low

AUD 25.50

52-week low date

2026-06-03

5Y price change

-2.69%

5Y return CAGR

0.71%

5Y total return

3.61%

6M price change

15.26%

6M total return

15.95%

All-time high

AUD 45.25

All-time high date

2025-08-25

All-time low

AUD 0.79

All-time low date

2000-01-07

Average true range (ATR)

AUD 0.58

Average volume

1.4M

Beta (5Y)

0.75

Change from 52-week high

-12.35%

Change from 52-week low

37.77%

Change from all-time high

-22.36%

Change from all-time low

4,353.6%

Change from open

-0.9%

Day's gap

-0.14%

Dollar volume

AUD 76.8M

High price

AUD 35.72

Low price

AUD 35.01

Monthly RSI

52.2

Open price

AUD 35.45

Position in 52-week range

16.9%

Previous close

AUD 35.50

Price vs 150-day SMA

15.06%

Price vs 20-day SMA

4.5%

Price vs 200-day SMA

10.45%

Price vs 50-day SMA

8.04%

Relative volume

1.51

RSI

67.58

Sharpe ratio

-0.29

Sharpe ratio (3Y)

0.52

Sharpe ratio (5Y)

0.03

Sortino ratio

-0.21

Sortino ratio (3Y)

0.94

Sortino ratio (5Y)

0.24

Volume

2.2M

Weekly RSI

60.34

YTD price change

-2.25%

YTD total return

-1.45%

Metric

Value

Float

139.8M

Shares change (QoQ)

-0.51%

Shares change (YoY)

-0.87%

Shares held by insiders

0.49%

Shares held by institutions

80.41%

Short ratio

9.1 days

ASX/RMD (ASX/RMD)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/RMD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/RMD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/RMD

Frequently asked questions

ASX/RMD (ASX/RMD)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/RMD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/RMD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/RMD

Frequently asked questions